3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 2
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
172
Gynecologic
18
Thoracic
12
Head & Neck
7
Genitourinary
6
Breast
6
Sarcoma
5
Dermatologic
4
Other solid neoplasm
2
Plasma cell
1
Myeloid
1
Endocrine
1
CNS
1
Conditions
Mesothelioma, Malignant
57
Mesothelioma
35
Unspecified Adult Solid Tumor, Protocol Specific
25
Solid Tumor
9
Advanced Solid Tumors
8
Advanced Solid Tumor
7
Solitary Fibrous Tumor, Pleural
6
Carcinoma, Non-Small-Cell Lung
6
Sarcoma
4
Lung Neoplasms
4
Solid Tumors
3
Peritoneal Neoplasms
3
Neoplasms
3
Stomach Neoplasms
2
Retinoblastoma
2
Prostatic Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Head and Neck Neoplasms
2
Extensive Stage Small Cell Lung Cancer
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Central Nervous System Neoplasms
2
Breast Neoplasms
2
Advanced Solid Tumour
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Interventions
pembrolizumab
9
Hyperthermic Intraperitoneal Chemotherapy
3
fludarabine
2
budigalimab
2
Nivolumab
2
Ipilimumab
2
Cytoreduction Surgical Procedures
2
Cyclophosphamide
2
Cisplatin
2
venetoclax
1
tocilizumab
1
tislelizumab
1
talazoparib
1
spartalizumab
1
sodium thiosulfate
1
rovalpituzumab tesirine
1
regorafenib
1
milademetan
1
irinotecan sucrosofate
1
fludarabine phosphate
1
epacadostat
1
entinostat
1
atezolizumab
1
X-Rays
1
Surgical Procedures, Operative
1
Specimen Handling
1
Sirolimus
1
Quality of Life
1
Polymerase Chain Reaction
1
Platinum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Cisplatin
×
Other solid neoplasm
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled